1-methylnicotinamide attenuated inflammation and regulated flora in Necrotizing enterocolitis
PLOS One · 2025
DOI: 10.1371/journal.pone.0324068 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Lian Hou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell Biology and Therapy Laboratory, The Children's Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Enterocolitis, Necrotizing, Niacinamide, Inflammation, Gastrointestinal Microbiome. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Necrotizing enterocolitis(NEC) is a prevalent and destructive illness in neonates. Nicotinamide N-methyltransferase (NNMT) and its derivative, 1-methylnicotinamide (1-MNA), are known to be significant in conditions such as cardiovascular inflammation and renal tubular damage, and 1-MNA has been recognized for its anti-inflammatory effects in various diseases. However, the involvement of NNMT and 1-MNA in the development of NEC remains unclear.
Methods
We collected intestinal tissues and blood samples from children with NEC and control subjects for biochemical analysis. The NEC rats were induced by hypoxic cold stimulation and lipopolysaccharide, and control, NEC and NEC + 1-MNA groups were established. Neonatal rats were executed on the fourth day and blood, intestinal and fecal specimens were taken for subsequent testing.
Results
Elevated NNMT and 1-MNA were found in NEC children and NEC rats. Exogenous supplementation of 1-MNA to NEC rats reduced mortality, pathological and inflammatory damage, and inhibited activation of the TLR4-NF-κB pathway in neonatal rats. In addition, 1-MNA improved intestinal barrier function and modulated intestinal flora in NEC rats.
Conclusion
1-MNA attenuated NEC injury by seemingly inhibiting the TLR4-NF-κB pathway, improving intestinal barrier function and modulating intestinal flora. These findings suggest a potential therapeutic role for 1-MNA in NEC management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Stem Cell Biology and Therapy Laboratory, The Children's Hospital of Chongqing Medical University, Chongqing, China.
ORCID-Profile: Quan Kang
Zitieren
APA
Hou, L., Du, J., Li, J., Luo, Q., & Kang, Q. (2025). 1-methylnicotinamide attenuated inflammation and regulated flora in Necrotizing enterocolitis. PLOS One. https://doi.org/10.1371/journal.pone.0324068
Vancouver
Hou L, Du J, Li J, Luo Q, Kang Q. 1-methylnicotinamide attenuated inflammation and regulated flora in Necrotizing enterocolitis. PLOS One. 2025. doi:10.1371/journal.pone.0324068
BibTeX
@article{Hou2025,
author = {Hou, Lian and Du, Junbao and Li, Jinxin and Luo, Qing and Kang, Quan},
title = {1-methylnicotinamide attenuated inflammation and regulated flora in Necrotizing enterocolitis},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0324068}
}
EUVIMED